Expedeon Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Cambridge, ENG
Total Funding:$6.5M
Industry:Biotech
Founded:N/A
Lead Investor(s):N/A

Industry Ranking

Estimated Revenue & Financials

  • Expedeon's estimated annual revenue is currently $11M per year.
  • Expedeon's estimated revenue per employee is $155,000
  • Expedeon's total funding is $6.5M.

Employee Data

  • Expedeon has 71 Employees.
  • Expedeon grew their employee count by 39% last year.
  • Expedeon currently has 1 job openings.

Expedeon is a world-leading expert in cutting-edge innovative reagents and services for life sciences and diagnostics, with application across workflows including: protein electrophoresis; liquid biopsy; whole genome amplification; antibody- and protein-labeling; and immunoassay development. Our cutting-edge offerings include off-the-shelf products, and custom services, supporting scientists from academia through to commercial manufacturing across the life sciences and diagnostic industry. Expedeon's dedicated team of experts has the flexibility to develop and supply consistently high quality products both off-the-shelf and to customer specification. We are constantly innovating to provide high quality, easy-to-use, cost-effective solutions, to minimize hands-on time for researchers. All our products are stringently QC tested, and are designed to save scientists time and costs. Expedeon is wholly owned by SYGNIS AG and has laboratory facilities and commercial sites in the UK, USA, Singapore, Germany and Spain. Expedeon provides fast, global delivery. Off-the-shelf products are available with next-day delivery and quick turnaround times are offered on custom product generation.

keywords:Consulting,Cleantech,Construction,Enterprise Software,Marketing,Wind Power